CD4 and graft versus host disease: Comparing the two donor cell doses to each other, significantly greater reduction of host cell subsets was noted for the 5M dose for all parameters in Fig. 1A-1E except for F1 CD4 T cells, where the GVHD-associated reductions did not differ significantly between the two doses (Fig. 1C, Table 1B).